{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:10:51Z","timestamp":1791216651220,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shanghai Key Laboratory of Medical Fungal Molecular Biology Open Project Foundation","award":["14DZ2272900"],"award-info":[{"award-number":["14DZ2272900"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fungal bloodstream infections (FBI) among intensive care unit (ICU) patients are increasing. Our objective was to characterize the fungal pathogens that cause bloodstream infections and determine the epidemiology and risk factors for patient mortality among ICU patients in Meizhou, China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Eighty-one ICU patients with FBI during their stays were included in the study conducted from January 2008 to December 2017. Blood cultures were performed and the antimicrobial susceptibility profiles of the resulting isolates were determined. Logistic multiple regression and ROC curve analysis were used to assess the risk factors for mortality among the cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The prevalence of FBI in ICU patients was 0.38% (81\/21,098) with a mortality rate of 36% (29\/81). Ninety-eight strains of bloodstream-infecting fungi, mainly\n                      <jats:italic>Candida<\/jats:italic>\n                      spp., were identified from these patients.\n                      <jats:italic>Candida albicans<\/jats:italic>\n                      was most common (43%). Two strains of\n                      <jats:italic>C. parapsilosis<\/jats:italic>\n                      were no-sensitive to caspofungin,\n                      <jats:italic>C. glabrata<\/jats:italic>\n                      were less than 80% sensitive to azole drugs. Logistic multiple regression showed that age, serum albumin, APACHE II score, three or more underlying diseases, and length of stay in ICU were independent risk factors for mortality in FBI. ROC curve analysis showed that APACHE II scores &gt;\u200919 and serum albumin \u226425\u2009g\/L were the best predictors of mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Candida spp. predominated with high mortality rates among cases of FBI in ICU. Thus, clinical staff should enhance overall patient monitoring and concurrently monitor fungal susceptibility to reduce mortality rates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05291-1","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T09:03:00Z","timestamp":1597395780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Analysis of fungal bloodstream infection in intensive care units in the Meizhou region of China: species distribution and resistance and the risk factors for patient mortality"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5442-6312","authenticated-orcid":false,"given":"Guangwen","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqing","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuenong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cailing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,14]]},"reference":[{"key":"5291_CR1","first-page":"21","volume":"145","author":"G Aguirre-Avalos","year":"2009","unstructured":"Aguirre-Avalos G, Mijangos-Mendez JC, Zavala-Silva ML, Coronado-Magana H, Amaya-Tapia G. Bacteremia caused by Acinetobacter baumannii among patients in critical care. Gac Med Mex. 2009;145:21\u20135.","journal-title":"Gac Med Mex"},{"key":"5291_CR2","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1086\/378745","volume":"37","author":"O Gudlaugsson","year":"2003","unstructured":"Gudlaugsson O, Gillespie S, Lee K, Vande BJ, Hu J, Messer S, et al. Attributable mortality of nosocomial Candidemia, Revisited. Clin Infect Dis. 2003;37:1172\u20137.","journal-title":"Clin Infect Dis"},{"issue":"suppl. 9","key":"5291_CR3","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1128\/JCM.39.9.3254-3259.2001","volume":"39","author":"MA Pfaller","year":"2001","unstructured":"Pfaller MA, Diekema DJ, Jones RN, Sader HS, Fluit AC, Hollis RJ, et al. International surveillance of blood stream infect ions due to Candida species:frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTY antimicrobial surveillance program. J Clin Microbiol. 2001;39(suppl. 9):3254\u20139.","journal-title":"J Clin Microbiol"},{"key":"5291_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/TCRM.S40160","volume":"10","author":"N Yapar","year":"2014","unstructured":"Yapar N. Epidemiology and risk factors for invasive candidiasis. Ther Clin Risk Manag. 2014;10:95\u2013105.","journal-title":"Ther Clin Risk Manag"},{"key":"5291_CR5","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1093\/jac\/dkx047","volume":"72","author":"B Chapman","year":"2017","unstructured":"Chapman B, Slavin M, Marriott D, Halliday C, Kidd S, Arthur I, et al. Changing epidemiology of candidaemia in Australia. J Antimicrob Chemother. 2017;72:1103\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"5291_CR6","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1128\/JCM.02566-12","volume":"51","author":"LR Asmundsdottir","year":"2013","unstructured":"Asmundsdottir LR, Erlendsdottir H, Gottfredsson M. Nationwide study of candidemia, antifungal use, and antifungal drug resistance in Iceland, 2000 to 2011. J Clin Microbiol. 2013;51:841\u20138.","journal-title":"J Clin Microbiol"},{"key":"5291_CR7","doi-asserted-by":"publisher","first-page":"e621","DOI":"10.1016\/j.ijid.2013.02.010","volume":"17","author":"A Kreusch","year":"2013","unstructured":"Kreusch A, Karstaedt AS. Candidemia among adults in Soweto, South Africa, 1990\u20132007. Int J Infect Dis. 2013;17:e621\u20133.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"5291_CR8","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3201\/eid2404.171807","volume":"24","author":"N Poowanawittayakom","year":"2018","unstructured":"Poowanawittayakom N, Dutta A, Stock S, Touray S, Levitz SM. Reemergence of intravenous drug use as risk factor for candidemia, massachusetts, usa. Emerg Infect Dis. 2018;24(4):631\u20137.","journal-title":"Emerg Infect Dis"},{"issue":"suppl. 4","key":"5291_CR9","doi-asserted-by":"publisher","first-page":"e0195743","DOI":"10.1371\/journal.pone.0195743","volume":"13","author":"Z Khan","year":"2018","unstructured":"Khan Z, Ahmad S, Al-Sweih N, Joseph L, Alfouzan W, Asadzadeh M. Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait. PLoS One. 2018;13(suppl. 4):e0195743.","journal-title":"PLoS One"},{"key":"5291_CR10","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.cmi.2015.06.010","volume":"21","author":"BH Tan","year":"2015","unstructured":"Tan BH, Chakrabarti A, Li RY, Patel AK, Watcharananan SP, Liu Z, et al. Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study. Clin Microbiol Infect. 2015;21:946\u201353.","journal-title":"Clin Microbiol Infect"},{"key":"5291_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s15010-015-0845-z","volume":"44","author":"F Barchiesi","year":"2016","unstructured":"Barchiesi F, Orsetti E, Gesuita R, Skrami E, Manso E, Candidemia SG. Epidemiology, clinical characteristics, and outcome of candidemia in a tertiary referral center in Italy from 2010 to 2014. Infection. 2016;44:205\u201313.","journal-title":"Infection."},{"key":"5291_CR12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jmii.2012.08.001","volume":"46","author":"LY Chen","year":"2013","unstructured":"Chen LY, Kuo SC, Wu HS, Yang SP, Chan YJ, Chen LK, et al. Associated clinical characteristics of patients with candidemia among different Candida species. Microbiol Immunol Infect. 2013;46:463\u20138.","journal-title":"Microbiol Immunol Infect"},{"issue":"suppl. 4","key":"5291_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.diagmicrobio.2004.03.011","volume":"49","author":"F Barchiesi","year":"2004","unstructured":"Barchiesi F, Caggiano G, Di Francesco LF, Montagna MT, Barbuti S, Scalise G. Outbreak of fungemia due to Candida parapsilosis in a pediatric oncology unit. Diagn Microbiol Infect Dis. 2004;49(suppl. 4):269\u201371.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"suppl. 1","key":"5291_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1099\/jmm.0.045054-0","volume":"62","author":"JCO Sardi","year":"2013","unstructured":"Sardi JCO, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJ. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol. 2013;62(suppl. 1):10\u201324.","journal-title":"J Med Microbiol"},{"key":"5291_CR15","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","volume":"62","author":"PG Pappas","year":"2015","unstructured":"Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the Management of Candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2015;62:e1\u2013e50.","journal-title":"Clin Infect Dis"},{"key":"5291_CR16","first-page":"179","volume":"30","author":"M Nucci","year":"2013","unstructured":"Nucci M, Thompson-Moya L, Guzman-Blanco M, Tiraboschi IN, Cortes JA, Echevarria J, et al. Recommendations for the management of candidemia in adults in Latin America. Rev Iberoam Micol. 2013;30:179\u201388.","journal-title":"Rev Iberoam Micol"},{"key":"5291_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00134-014-3603-2","volume":"41","author":"A Chakrabarti","year":"2015","unstructured":"Chakrabarti A, Sood P, Rudramurthy SM, Chen S, Kaur H, Capoor M, et al. Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Med. 2015;41:285\u201395.","journal-title":"Intensive Care Med"},{"issue":"suppl. 1","key":"5291_CR18","first-page":"21","volume":"145","author":"G Aguirre-Avalos","year":"2009","unstructured":"Aguirre-Avalos G, Mijangos-M\u00e9ndez JC, Zavala-Silva ML, Coronado-Magana H, Amaya-Tapia G. Bacteremia caused by Acinetobacter baumannii among patients in critical care. Gac Med Mex. 2009;145(suppl. 1):21\u20135.","journal-title":"Gac Med Mex"},{"issue":"suppl. 7","key":"5291_CR19","doi-asserted-by":"publisher","first-page":"e101510","DOI":"10.1371\/journal.pone.0101510","volume":"9","author":"MA Pfaller","year":"2014","unstructured":"Pfaller MA, Andes DR, Diekema DJ, Horn DL, Reboli AC, Rotstein C, et al. Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the prospective antifungal therapy (PATH) registry 2004\u20132008. PLoS One. 2014;9(suppl. 7):e101510.","journal-title":"PLoS One"},{"issue":"suppl. 1","key":"5291_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ijantimicag.2013.09.005","volume":"43","author":"H Wisplinghoff","year":"2014","unstructured":"Wisplinghoff H, Ebbers J, Geurtz L, Stefanik D, Major Y, Edmond MB, et al. Nosocomial bloodstreaminfections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities. Int J Antimicrob Agents. 2014;43(suppl. 1):78\u201381.","journal-title":"Int J Antimicrob Agents"},{"key":"5291_CR21","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/archinte.169.4.379","volume":"169","author":"I Lee","year":"2009","unstructured":"Lee I, Fishman NO, Zaoutis TE, Morales KH, Weiner MG, Synnestvedt M, et al. Risk factors for fluconazole-resistant Candida glabrata bloodstream infections. Arch Intern Med. 2009;169:379\u201383.","journal-title":"Arch Intern Med"},{"issue":"Suppl 1","key":"5291_CR22","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.arr.2010.07.001","volume":"9","author":"Z Chen","year":"2010","unstructured":"Chen Z, Yu J, Song Y, Chui D. Aging Beijing: challenges and strategies of health care for the elderly. Ageing Res Rev. 2010;9(Suppl 1):S2\u20135.","journal-title":"Ageing Res Rev"},{"key":"5291_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.diagmicrobio.2007.01.005","volume":"58","author":"M Bassetti","year":"2007","unstructured":"Bassetti M, Trecarichi EM, Righi E, Sanguinetti M, Bisio F, Posteraro B, et al. Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. Diagn Microbiol Infect Dis. 2007;58:325\u201331.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"5291_CR24","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/MCC.0b013e32833e84d2","volume":"16","author":"MC Arendrup","year":"2010","unstructured":"Arendrup MC. Epidemiology of invasive candidiasis. Curr Opin Crit Care. 2010;16:445\u201352.","journal-title":"Curr Opin Crit Care"},{"key":"5291_CR25","first-page":"1","volume":"54","author":"MA Pfaller","year":"2016","unstructured":"Pfaller MA, Castanheira M. Nosocomial candidiasis: antifungal stewardship and the importance of rapid diagnosis. Med Mycol. 2016;54:1\u201322.","journal-title":"Med Mycol"},{"issue":"5","key":"5291_CR26","doi-asserted-by":"publisher","first-page":"364","DOI":"10.4103\/ijccm.IJCCM_4_18","volume":"22","author":"N Bansal","year":"2018","unstructured":"Bansal N, Gopalakrishnan R, Sethuraman N, Ramakrishnan N, Nambi P, Kumar D, et al. Experience with \u03b2-d-glucan assay in the management of critically ill patients with high risk of invasive candidiasis: an observational study. Indian J Crit Care Med. 2018;22(5):364.","journal-title":"Indian J Crit Care Med"},{"key":"5291_CR27","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1097\/TA.0b013e31824d1085","volume":"72","author":"ME Lissauer","year":"2012","unstructured":"Lissauer ME, Leekha S, Preas MA, Thom KA, Johnson SB. Risk factors for central line-associated bloodstream infections in the era of best practice. J Acute Care Surg. 2012;72:1174\u201380.","journal-title":"J Acute Care Surg"},{"key":"5291_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jcrc.2010.10.007","volume":"26","author":"JH Lee","year":"2011","unstructured":"Lee JH, Kim J, Kim K, Jo YH, Rhee J, Kim TY, et al. Albumin and C-reactive protein have prognostic significance in patients with community-acquired neumonia. J Crit Carc. 2011;26:287\u201394.","journal-title":"J Crit Carc"},{"key":"5291_CR29","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1001\/archsurg.137.7.805","volume":"137","author":"M Delgado-Rodriguez","year":"2002","unstructured":"Delgado-Rodriguez M, Medina-Cuadros M, Gomez-Ortega A, Martinez-Gallego G, Mariscal-Ortiz M, Martinez-Gonzalez MA, et al. Cholesterol and serum alhumin levels as predictors of cross infection, death and length of hospital stay. Arch Surg. 2002;137:805\u201312.","journal-title":"Arch Surg"},{"key":"5291_CR30","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jcrc.2009.12.004","volume":"25","author":"A Artero","year":"2010","unstructured":"Artero A, Zaragoza R, Camarena J, Sancho S, Gonzalez R, Nogueira JM. Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock. J Crit Care. 2010;25:276\u201381.","journal-title":"J Crit Care"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05291-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05291-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05291-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T19:09:38Z","timestamp":1628881778000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05291-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,14]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5291"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05291-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.12729\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.12729\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.12729\/v2","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,14]]},"assertion":[{"value":"25 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local institutional review board of the Medical College, Jiaying University; informed consent was not required from patients because of the observational nature of the surveillance.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"599"}}